CONCORDBIOPharmaceuticals

Concord Biotech LtdFinancial Ratios & Key Metrics

1018.40
-2.34%
P/E Ratio46.19xIndustry: 31.77x
ROE21.27%Return on equity
ROCE28.25%Return on capital
Debt/Equity0.00Debt free ✓
💎

Valuation & Profitability

P/E Ratio
46.19x
Industry Average P/E
31.77x
Dividend Yield
0.75%
Market Cap
₹14.96K (Cr)
Sales Growth 5Y
18.56%
Profit Growth 5Y
18.55%
EPS Growth 5Y
-26.61%
OPM 5Y Avg
42.73%
📉

Price Returns

1 Month
-0.75%
3 Months
-15.14%
6 Months
-23.62%
1 Year
-32.65%
52W Low
995
Current
1018
52W High
2150
2% of 52-week range — Near lows
🔬

Technical Indicators

20RSI 14
Oversold
Selling pressure is heavy — potential reversal zone.
SMA 50
1186
▼ Price below SMA 50 — Bearish
SMA 200
1502
▼ Long-term downtrend
Volume Signal
31% of avg
Below average volume — low conviction

Technical indicators are for educational purposes only. Not investment advice.

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.